Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 516 citing articles:

Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases
Cara L. Mack, David H. Adams, David N. Assis, et al.
Hepatology (2019) Vol. 72, Iss. 2, pp. 671-722
Open Access | Times Cited: 715
Hepatitis B virus infection
Man‐Fung Yuen, Ding‐Shinn Chen, Geoffrey Dusheiko, et al.
Nature Reviews Disease Primers (2018) Vol. 4, Iss. 1
Closed Access | Times Cited: 675
Update of the statements on biology and clinical impact of occult hepatitis B virus infection
Giovanni Raimondo, Stephen Locarnini, Teresa Pollicino, et al.
Journal of Hepatology (2019) Vol. 71, Iss. 2, pp. 397-408
Open Access | Times Cited: 431
Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy
Mindie H. Nguyen, Grace Lai‐Hung Wong, Edward Gane, et al.
Clinical Microbiology Reviews (2020) Vol. 33, Iss. 2
Open Access | Times Cited: 417
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study
Shukui Qin, Stephen L. Chan, Shanzhi Gu, et al.
The Lancet (2023) Vol. 402, Iss. 10408, pp. 1133-1146
Closed Access | Times Cited: 355
Circulating and intrahepatic antiviral B cells are defective in hepatitis B
Alice R. Burton, Laura J. Pallett, Laura E. McCoy, et al.
Journal of Clinical Investigation (2018) Vol. 128, Iss. 10, pp. 4588-4603
Open Access | Times Cited: 259
KASL clinical practice guidelines for management of chronic hepatitis B

Clinical and Molecular Hepatology (2019) Vol. 25, Iss. 2, pp. 93-159
Open Access | Times Cited: 191
Epigenetic regulation of hepatitis B virus covalently closed circular DNA: Implications for epigenetic therapy against chronic hepatitis B
Xupeng Hong, Elena S. Kim, Haitao Guo
Hepatology (2017) Vol. 66, Iss. 6, pp. 2066-2077
Open Access | Times Cited: 180
Occult hepatitis B infection and hepatocellular carcinoma: Epidemiology, virology, hepatocarcinogenesis and clinical significance
Lung‐Yi Mak, Danny Ka‐Ho Wong, Teresa Pollicino, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 4, pp. 952-964
Closed Access | Times Cited: 167
Hepatitis B virus reactivation in cancer patients with positive Hepatitis B surface antigen undergoing PD-1 inhibition
Xuanye Zhang, Yixin Zhou, Chen Chen, et al.
Journal for ImmunoTherapy of Cancer (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 150
Prevalence of Chronic Hepatitis B Virus Infection in the United States
Joseph K. Lim, Mindie H. Nguyen, W. Ray Kim, et al.
The American Journal of Gastroenterology (2020) Vol. 115, Iss. 9, pp. 1429-1438
Open Access | Times Cited: 148
Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023
Erin E. Conners, Lakshmi Panagiotakopoulos, Megan G. Hofmeister, et al.
MMWR Recommendations and Reports (2023) Vol. 72, Iss. 1, pp. 1-25
Open Access | Times Cited: 141
AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
Robert J. Fontana, Iris Liou, Adrian Reuben, et al.
Hepatology (2022) Vol. 77, Iss. 3, pp. 1036-1065
Open Access | Times Cited: 113
APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy
George Lau, Ming‐Lung Yu, Grace Lai‐Hung Wong, et al.
Hepatology International (2021) Vol. 15, Iss. 5, pp. 1031-1048
Open Access | Times Cited: 107
The scientific basis of combination therapy for chronic hepatitis B functional cure
Seng Gee Lim, Thomas F. Baumert, Carolina Boni, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 4, pp. 238-253
Open Access | Times Cited: 93
KASL clinical practice guidelines for management of chronic hepatitis B

Clinical and Molecular Hepatology (2022) Vol. 28, Iss. 2, pp. 276-331
Open Access | Times Cited: 88
Acute-on-chronic liver failure (ACLF): the ‘Kyoto Consensus’—steps from Asia
Ashok Choudhury, Anand V. Kulkarni, Vinod Arora, et al.
Hepatology International (2025) Vol. 19, Iss. 1, pp. 1-69
Open Access | Times Cited: 2
Quantitation of HBV cccDNA in anti-HBc-positive liver donors by droplet digital PCR: A new tool to detect occult infection
Gian Paolo Caviglia, Maria Lorena Abate, Francesco Tandoi, et al.
Journal of Hepatology (2018) Vol. 69, Iss. 2, pp. 301-307
Closed Access | Times Cited: 154
Hepatitis B surface antigen seroclearance: Immune mechanisms, clinical impact, importance for drug development
Issam Tout, Dimitri Loureiro, Abdellah Mansouri, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 2, pp. 409-422
Open Access | Times Cited: 126
Restoring, releasing or replacing adaptive immunity in chronic hepatitis B
Mala K. Maini, Alice R. Burton
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 16, Iss. 11, pp. 662-675
Open Access | Times Cited: 111
Recent developments with immunotherapy for hepatocellular carcinoma
Oliver Waidmann
Expert Opinion on Biological Therapy (2018) Vol. 18, Iss. 8, pp. 905-910
Closed Access | Times Cited: 105
Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop
Hyung Joon Yim, Ji Hoon Kim, Jun Yong Park, et al.
Clinical and Molecular Hepatology (2020) Vol. 26, Iss. 4, pp. 411-429
Open Access | Times Cited: 85
Longitudinal changes of liver function and hepatitis B reactivation in COVID‐19 patients with pre‐existing chronic hepatitis B virus infection
Jiaye Liu, Tingyan Wang, Qingxian Cai, et al.
Hepatology Research (2020) Vol. 50, Iss. 11, pp. 1211-1221
Open Access | Times Cited: 79
Perioperative Evaluation and Management of Patients With Cirrhosis: Risk Assessment, Surgical Outcomes, and Future Directions
Kira L. Newman, Kay M. Johnson, Paul B. Cornia, et al.
Clinical Gastroenterology and Hepatology (2019) Vol. 18, Iss. 11, pp. 2398-2414.e3
Open Access | Times Cited: 78
Hepatitis B Virus Reactivation: Risk Factors and Current Management Strategies
Danielle Smalls, Reagan E. Kiger, LeAnn B. Norris, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2019) Vol. 39, Iss. 12, pp. 1190-1203
Open Access | Times Cited: 76
Page 1 - Next Page

Scroll to top